Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Type 1 Diabetes · Diabetes Mellitus, Type 1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States

    Contact: Study coordinator (Francesco Vendrame, MD) · (305) 243-5321
    Contact: Principal Investigator (Francesco Vendrame, MD)
    Rodolfo Alejandro, MD (Sub-investigator)
Study leads
  • Francesco Vendrame, MD

    Principal Investigator

    University of Miami, Diabetes Research Institute